Latest News about RDHL
Recent news which mentions RDHL
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
From Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
June 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 11, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 04, 2022
From Benzinga
26 Stocks Moving in Thursday's Pre-Market Session
April 21, 2022
From Benzinga
RedHill Biopharma Says Opaganib Can Potentially Work Against COVID-19 Omicron Subvariants
April 11, 2022
Tickers
RDHL
From Benzinga
64 Biggest Movers From Yesterday
March 18, 2022
From Benzinga
Earnings Scheduled For March 17, 2022
March 17, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
From Benzinga
RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients
March 01, 2022
Tickers
RDHL
From Benzinga
RedHill Biopharma's COVID-19 Antiviral Cuts Mortality By 70% In Remdesivir Treated Patients
February 07, 2022
From Benzinga
18 Stocks Moving in Friday's Pre-Market Session
January 14, 2022
From Benzinga
RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance
January 13, 2022
Tickers
RDHL
From Benzinga
63 Biggest Movers From Yesterday
December 31, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 30, 2021
From Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
December 30, 2021
From Benzinga
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday
December 14, 2021
From Benzinga
RedHill Biopharma's Talicia Recommended For H. Pylori Infection
December 09, 2021
Tickers
RDHL
From Benzinga
From InvestorPlace
RedHill Biopharma Says Opaganib Mechanism Against COVID-19 Not Impacted By Omicron Mutations
December 06, 2021
Tickers
RDHL
From Benzinga
RedHill Biopharma's Talicia For Bacterial Infections Shows Efficacy Irrespective of Patient BMI
December 02, 2021
Tickers
RDHL
From Benzinga
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
November 30, 2021
From Benzinga
Earnings Scheduled For November 30, 2021
November 30, 2021
From Benzinga
52 Biggest Movers From Friday
November 22, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|